Antimicrobial resistance (AMR) is estimated to be the number one cause of death globally by 2050!
As AMR is unnoticed by most, the silent pandemic keeps spreading.
Who is responsible for the silent pandemic?
ESKAPE
bacteria
Where are the antibiotics to treat AMR?
The antibiotic pipeline has run dry
Golden Age
Discovery Void (1970s-2000s)
Today
The 1940s to 1960s are known as the golden age of antibiotic discovery. Scientists extracted antibiotic natural products from fungi and bacteria, while also producing synthetic and semi-synthetic compounds in huge numbers. Yet even then, penicillin had to be modified due to resistances emerging, showing that microbes evolved faster than expected.
The initial flood of new antibiotic classes emerging from diverse natural sources led to their overuse and with it came resistance. As natural product scaffolds were seen as largely explored, the “low-hanging fruits harvested”, research on them receded, while chemical synthesis became the main driver of innovation.
Antibiotic innovation came to a halt. Only derivatives of already known classes reached the market, while no new ones appeared. Pharmaceutical companies turned to more profitable long-term drugs like antihypertensives, leaving short-course antibiotics at a disadvantage. With research abandoned, resistance continued to build, setting the stage for the global health crisis we face today - AMR, the silent pandemic.
We need new
Antibiotics
!
Nature Shows the Way
Using nature's peptide antibiotic producers.
NRPS produce peptides with antimicrobial activity
NRPS are enzymes in soil-dwelling bacteria
Non-ribosomal Peptide Synthetase
Peptide
Bioactive compound
Our solution:
The NRPieces Platform
Combining NRPS from different organisms
Generating peptide derivates with antimicrobial activity
New to nature peptide
We introduce the
N
R
P
iece
S
Library!
A tool for the discovery of
new peptide antibiotics
by derivatization
Unlocking Nature’s Antibiotic Toolbox to outpace resistance.